What’s Trending?

AstraZeneca
Clinical trials for the AstraZeneca Oxford coronavirus vaccine, AZD1222, have resumed across the world with regulators in the US, UK, Brazil, South Africa and Japan confirming that it was safe to do so. The Food and Drug Administration (FDA) authorised the restart in the US, following the resumption of trials in [...]
Sat, Oct 24, 2020
Source WorldPharmaNews
Former Indivior CEO gets 6 months in jail for role in Suboxone marketing scheme kblankenship Fri, 10/23/2020 - 11:13 [...]
Fri, Oct 23, 2020
Source FiercePharma
Deaths rattle South Korea's seasonal flu vaccination, but authority presses ahead with free scheme aliu Fri, 10/23/2020 - 10:20 [...]
Fri, Oct 23, 2020
Source FiercePharma
Merck, Pfizer pneumonia vaccines running low in EU as researchers fight COVID-19: report kblankenship Fri, 10/23/2020 - 10:10 [...]
Fri, Oct 23, 2020
Source FiercePharma
Gilead scored a full FDA approval for COVID-19 drug Veklury, but experts aren't convinced esagonowsky Fri, 10/23/2020 - 09:28 [...]
Fri, Oct 23, 2020
Source FiercePharma
CureVac
CureVac N.V. (Nasdaq: CVAC), a clinical-stage biopharmaceutical company developing a new class of transformative medicines based on messenger ribonucleic acid ("mRNA"), today announced data from preclinical studies of its investigational SARS-CoV-2 vaccine candidate, CVnCoV, in mice and hamsters. The vaccine candidate elicited balanced humoral and cellular immune responses, featuring high [...]
Fri, Oct 23, 2020
Source WorldPharmaNews
Agreement will see partners develop SARS-CoV-2 neutralising monoclonal antibodies [...]
Fri, Oct 23, 2020
Source PharmaTimes
Collaboration will involve applying machine learning for research into rare blood diseases [...]
Fri, Oct 23, 2020
Source PharmaTimes
Keytruda backed for monotherapy treatment but combination therapy rejected [...]
Fri, Oct 23, 2020
Source PharmaTimes
Antiviral becomes first COVID-19 treatment approved in the US [...]
Fri, Oct 23, 2020
Source PharmaTimes
FDA
The U.S. Food and Drug Administration approved the antiviral drug Veklury (remdesivir) for use in adult and pediatric patients 12 years of age and older and weighing at least 40 kilograms (about 88 pounds) for the treatment of COVID-19 requiring hospitalization. Veklury should only be administered in a hospital or [...]
Thu, Oct 22, 2020
Source WorldPharmaNews
The AstraZeneca Oxford COVID-19 vaccine (ChAdOx1 nCoV-19 and also known as AZD1222) now undergoing Phase III clinical trials, has already undergone rigorous testing to ensure the highest standards of quality and safety. Now a team at Bristol University has used recently developed techniques to further validate that the vaccine accurately [...]
Thu, Oct 22, 2020
Source WorldPharmaNews
Sponsors submitting pediatric study plans should consider whether a product affects adults and children similarly when choosing an approach, the FDA says. [...]
Fri, Jan 16, 2015
Source FDANews